Home Oxygen Use to Treat Cluster Headache (CH) - RETIRED | CMS Coverage Update

Summary: The Centers for Medicare & Medicaid Services modified its coverage policy for home oxygen use to treat cluster headache, effective May 15, 2026, retiring the existing policy. Here's what billing teams need to do.

This retirement matters because it signals a formal CMS position change on a coverage area that has generated real claim denial activity for years. The Centers for Medicare & Medicaid Services home oxygen cluster headache coverage policy has existed in a gray zone — some MACs covered it under certain conditions, others didn't. Retiring the policy closes that ambiguity, but it also creates immediate billing questions for practices and DME suppliers who have been billing home oxygen for cluster headache patients. The policy does not list specific codes, so your billing team needs to act on the policy-level change and assess your current claims before May 15, 2026.

Quick-Reference Table

CMS Home Oxygen for Cluster Headache Coverage Criteria and Medical Necessity Requirements 2026

Let's be direct about what a policy retirement means in CMS billing terms. When CMS retires a coverage policy, it doesn't automatically mean the service becomes non-covered. It means CMS is removing its formal policy framework for that indication. Coverage decisions typically revert to the local level — your Medicare Administrative Contractor.

That shift has real consequences for medical necessity documentation. Under an active CMS policy, you had a defined standard to document against. Without it, your MAC sets the bar. That bar varies by region, and it can change without the national-level visibility that a CMS policy update would trigger.

Whether home oxygen therapy for cluster headache is covered under Medicare has always been complicated. Cluster headache is a primary headache disorder — not a respiratory condition. Standard Medicare home oxygen coverage requires documented hypoxemia, which cluster headache patients typically don't have. The previous CMS coverage policy addressed this gap by creating a framework specifically for this neurological indication. Retiring it removes that framework entirely.

Prior authorization requirements for home oxygen vary by MAC and by supplier type. If your practice or DME supplier was relying on the now-retired CMS policy to support prior authorization approvals, that documentation strategy no longer applies after May 15, 2026. Talk to your MAC directly before that date to understand what replaces it — if anything does.

The real issue here is reimbursement continuity for existing patients. If a patient is currently receiving home oxygen for cluster headache under an approved prior auth, retirement of the policy mid-auth period creates a documentation problem. Your billing guidelines need to account for that transition, not just new claims going forward.

CMS Home Oxygen for Cluster Headache Exclusions and Non-Covered Indications

Because the policy is being retired rather than revised, CMS is not publishing new exclusion criteria. That's actually the more disruptive outcome for billing teams.

With a revised policy, you get updated criteria — what's in, what's out, what's experimental. A retirement gives you none of that. The absence of a national coverage framework means the exclusions are now whatever your MAC says they are. That's a harder standard to operationalize across a multi-state or multi-MAC billing operation.

Historically, CMS and most MACs treated home oxygen for cluster headache as a non-standard indication. The primary coverage pathway for durable medical equipment oxygen under Medicare — including portable and stationary concentrators — is tied to documented arterial blood gas levels or oxygen saturation thresholds. Cluster headache patients who don't meet those respiratory thresholds have no clear coverage path once this policy retires.

If you've been billing home oxygen for cluster headache under the existing policy framework, expect claim denial risk to increase after May 15, 2026, unless your MAC explicitly establishes a local coverage determination to fill the gap.

Coverage Indications at a Glance

The policy data provided does not include specific indication-level criteria. The table below reflects the coverage status based on the policy retirement and CMS's general home oxygen coverage framework. Confirm each row with your MAC before May 15, 2026.

CMS Home Oxygen for Cluster Headache Billing Guidelines and Action Items 2026

These are the steps your billing team and DME suppliers need to take before and after May 15, 2026.

CPT, HCPCS, and ICD-10 Codes for Home Oxygen for Cluster Headache Under This Policy

The policy data provided does not list specific CPT, HCPCS, or ICD-10 codes. This is itself a significant detail. A retirement without code-level specificity means CMS is not directing MAC or billing system updates at the code level — it's removing the policy framework wholesale.

For reference, your billing team should be aware that home oxygen therapy for DME purposes is typically billed using HCPCS E-codes for oxygen equipment and supplies. Cluster headache is classified under ICD-10 in the primary headache disorder range. This policy does not specify which codes were covered under the now-retired framework, so you cannot infer coverage status from code assignment alone.

What This Means for Code-Level Billing

Because no codes are specified in the policy data, billing teams should not assume that existing code combinations that previously passed edits will continue to do so after May 15, 2026. Payer-side edit logic tied to a now-retired coverage policy can be unpredictable. Test your claims against your MAC's current edits before the effective date if your volume justifies it.

No Official Code Table Available

Do not invent code associations based on the policy title. Verify the applicable codes with your MAC or your coding team against current LCD language before billing home oxygen for cluster headache after May 15, 2026.